Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Ominous Death Cross Forms On Fortinet's Chart

If history is any guide, there may be trouble ahead for shares of Fortinet (NASDAQ:FTNT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

This Foreboding Sign Looms Over Fox's Chart

If history is any guide, there may be trouble ahead for shares of Fox (NASDAQ:FOX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

5 Value Stocks To Watch In The Industrials Sector

What are Value Stocks?

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Market Volatile After Hot Inflation Report, As Apple, Techs Lag

The stock market remained volatile after the latest inflation report came in higher than expected, but indexes were mainly higher in midday trading.

Investors Business Daily

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021

Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or $0.50 loss per share. For comparison, net loss in the same period of 2021 was $12.7 million…

Benzinga

First Patient Dosed in Phase 2 Study of Intercept's OCA and Bezafibrate Combination for Primary Biliary Cholangitis

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) dosed first patient in a Phase 2 study evaluating a fixed-dose combination of obeticholic acid (OCA) and bezafibrate (BZF) for the treatment of patients with primary biliary cholangitis (PBC).

Benzinga

StoneCastle Financial's Earnings Outlook

StoneCastle Financial (NASDAQ:BANX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that StoneCastle Financial will report an earnings per share (EPS) of $0.46.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview For Biolase

Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Biolase will report an earnings per share (EPS) of $-0.68.

Benzinga

Expert Ratings for IAC/InterActive

Analysts have provided the following ratings for IAC/InterActive (NASDAQ:IAC) within the last quarter:

Benzinga

Earnings Preview: Dare Bioscience

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Dare Bioscience will report an earnings per share (EPS) of $-0.14.

Benzinga

What 10 Analyst Ratings Have To Say About Dentsply Sirona

Analysts have provided the following ratings for Dentsply Sirona (NASDAQ:XRAY) within the last quarter:

Benzinga

Earnings Preview For Boxlight

Boxlight (NASDAQ:BOXL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Boxlight will report an earnings per share (EPS) of $-0.06.

Benzinga

Preview: Aurora Cannabis's Earnings

Aurora Cannabis (NASDAQ:ACB) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Aurora Cannabis will report an earnings per share (EPS) of $-0.18.

Benzinga

4 Analysts Have This to Say About Kaltura

Analysts have provided the following ratings for Kaltura (NASDAQ:KLTR) within the last quarter:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Acacia Research Earnings Preview

Acacia Research (NASDAQ:ACTG) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Acacia Research will report an earnings per share (EPS) of $-0.01.

Benzinga

What 19 Analyst Ratings Have To Say About Peloton Interactive

Over the past 3 months, 19 analysts have published their opinion on Peloton Interactive (NASDAQ:PTON) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Affirm Holdings's Earnings: A Preview

Affirm Holdings (NASDAQ:AFRM) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Affirm Holdings will report an earnings per share (EPS) of $-0.54.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Upgrades

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Profrac Holding Corp To Start Trading Tomorrow

ProFrac Holding Corp (NASDAQ:PFHC) IPO will take place May, 12 on the NASDAQ exchange under the ticker PFHC. The company is offering shares at an expected price between $21.00 and $24.00 per share with an insider lock-up period of 180 days ending on November 08, 2022.

Benzinga

Premier's Return on Invested Capital Overview

According to Benzinga Pro, during Q3, Premier (NASDAQ:PINC) earned $39.07 million, a 49.41% increase from the preceding quarter. Premier's sales decreased to $347.83 million, a 8.28% change since Q2.

Benzinga

Looking Into Coca-Cola Consolidated's Return On Invested Capital

According to Benzinga Pro, during Q1, Coca-Cola Consolidated (NASDAQ:COKE) earned $93.39 million, a 388.77% increase from the preceding quarter. Coca-Cola Consolidated also posted a total of $1.40 billion in sales, a 0.14% increase since Q4.

Benzinga

Caesars Entertainment Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Caesars Entertainment (NASDAQ:CZR) reported Q1 sales of $2.29 billion. Earnings fell to a loss of $680.00 million, resulting in a 57.04% decrease from last quarter.

Benzinga

Cerner's Return on Invested Capital Overview

Pulled from Benzinga Pro data, Cerner (NASDAQ:CERN) posted Q1 earnings of $206.13 million, an increase from Q4 of 17.89%. Sales dropped to $1.43 billion, a 1.52% decrease between quarters.

Benzinga

Mid-Morning Market Update: Markets Mixed; US Inflation Rate Slows To 8.3%

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining 2% on Wednesday.

Benzinga

Why Wendy's Shares Are Plunging Today

Wendy's Co (NASDAQ:WEN) reported first-quarter FY22 sales growth of 6.2% year-on-year to $488.6 million, missing the consensus of $497.1 million. Adjusted revenues increased 6.8% to $396.1 million. Global Systemwide sales improved 4.2%, with Systemwide sales in the U.S. rising 2.4% and International improving 19.2%. Global same-restaurant sales growth was 2.4%. The company-operated restaurant…

1 … 427 428 429 430

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

283,235 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.